nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—hypertension—obesity	0.397	1	CtDrD
Fenoldopam—DRD1—obesity	0.113	0.586	CbGaD
Fenoldopam—DRD2—obesity	0.0799	0.413	CbGaD
Fenoldopam—ADRA1B—Phendimetrazine—obesity	0.0415	0.142	CbGbCtD
Fenoldopam—DRD1—Phenylpropanolamine—obesity	0.0374	0.128	CbGbCtD
Fenoldopam—ADRA1A—Phendimetrazine—obesity	0.0327	0.112	CbGbCtD
Fenoldopam—ADRA2C—Methamphetamine—obesity	0.0314	0.107	CbGbCtD
Fenoldopam—ADRA2B—Methamphetamine—obesity	0.0297	0.102	CbGbCtD
Fenoldopam—ADRA2A—Benzphetamine—obesity	0.0259	0.0885	CbGbCtD
Fenoldopam—ADRA1A—Benzphetamine—obesity	0.0248	0.0848	CbGbCtD
Fenoldopam—ADRA2A—Phenylpropanolamine—obesity	0.0247	0.0844	CbGbCtD
Fenoldopam—ADRA1A—Phenylpropanolamine—obesity	0.0237	0.0809	CbGbCtD
Fenoldopam—ADRA2A—Methamphetamine—obesity	0.0207	0.0707	CbGbCtD
Fenoldopam—Cardiac failure—Phentermine—obesity	0.000769	0.0152	CcSEcCtD
Fenoldopam—Sweating—Benzphetamine—obesity	0.000745	0.0147	CcSEcCtD
Fenoldopam—Sweating—Phendimetrazine—obesity	0.000679	0.0134	CcSEcCtD
Fenoldopam—Angina pectoris—Phentermine—obesity	0.000632	0.0125	CcSEcCtD
Fenoldopam—Flushing—Phendimetrazine—obesity	0.00059	0.0116	CcSEcCtD
Fenoldopam—Blood creatinine increased—Cimetidine—obesity	0.000582	0.0115	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Phentermine—obesity	0.00057	0.0112	CcSEcCtD
Fenoldopam—Myocardial infarction—Phentermine—obesity	0.000567	0.0112	CcSEcCtD
Fenoldopam—Palpitations—Methamphetamine—obesity	0.000556	0.011	CcSEcCtD
Fenoldopam—Palpitations—Benzphetamine—obesity	0.000536	0.0106	CcSEcCtD
Fenoldopam—Flushing—Phenylpropanolamine—obesity	0.000504	0.00993	CcSEcCtD
Fenoldopam—Tachycardia—Methamphetamine—obesity	0.000501	0.00988	CcSEcCtD
Fenoldopam—Palpitations—Phendimetrazine—obesity	0.000489	0.00964	CcSEcCtD
Fenoldopam—Leukocytosis—Sibutramine—obesity	0.000487	0.0096	CcSEcCtD
Fenoldopam—Tachycardia—Benzphetamine—obesity	0.000483	0.00953	CcSEcCtD
Fenoldopam—Creatinine increased—Sibutramine—obesity	0.000481	0.00947	CcSEcCtD
Fenoldopam—Hyperhidrosis—Benzphetamine—obesity	0.000479	0.00944	CcSEcCtD
Fenoldopam—Extrasystoles—Bupropion—obesity	0.000474	0.00934	CcSEcCtD
Fenoldopam—Insomnia—Methamphetamine—obesity	0.000465	0.00916	CcSEcCtD
Fenoldopam—Tension—Phenylpropanolamine—obesity	0.000464	0.00914	CcSEcCtD
Fenoldopam—Nervousness—Phenylpropanolamine—obesity	0.000459	0.00905	CcSEcCtD
Fenoldopam—Insomnia—Benzphetamine—obesity	0.000448	0.00883	CcSEcCtD
Fenoldopam—Tension—Phentermine—obesity	0.000444	0.00875	CcSEcCtD
Fenoldopam—Tachycardia—Phendimetrazine—obesity	0.000441	0.00869	CcSEcCtD
Fenoldopam—Constipation—Methamphetamine—obesity	0.000439	0.00866	CcSEcCtD
Fenoldopam—Nervousness—Phentermine—obesity	0.000439	0.00866	CcSEcCtD
Fenoldopam—Bradycardia—Cimetidine—obesity	0.000438	0.00863	CcSEcCtD
Fenoldopam—Hyperhidrosis—Phendimetrazine—obesity	0.000436	0.0086	CcSEcCtD
Fenoldopam—Blood urea increased—Sibutramine—obesity	0.000432	0.00851	CcSEcCtD
Fenoldopam—Leukocytosis—Bupropion—obesity	0.000424	0.00837	CcSEcCtD
Fenoldopam—Insomnia—Phendimetrazine—obesity	0.000408	0.00805	CcSEcCtD
Fenoldopam—Anxiety—Phenylpropanolamine—obesity	0.000401	0.0079	CcSEcCtD
Fenoldopam—Palpitations—Phentermine—obesity	0.0004	0.00788	CcSEcCtD
Fenoldopam—Constipation—Phendimetrazine—obesity	0.000386	0.00761	CcSEcCtD
Fenoldopam—Tension—Diethylpropion—obesity	0.000386	0.00761	CcSEcCtD
Fenoldopam—Chest pain—Phentermine—obesity	0.000385	0.00759	CcSEcCtD
Fenoldopam—Nervousness—Diethylpropion—obesity	0.000382	0.00753	CcSEcCtD
Fenoldopam—Tachycardia—Phenylpropanolamine—obesity	0.000376	0.00742	CcSEcCtD
Fenoldopam—Nasal congestion—Sibutramine—obesity	0.000365	0.00719	CcSEcCtD
Fenoldopam—Hypotension—Phenylpropanolamine—obesity	0.00036	0.0071	CcSEcCtD
Fenoldopam—Tachycardia—Phentermine—obesity	0.00036	0.0071	CcSEcCtD
Fenoldopam—Abdominal pain—Phendimetrazine—obesity	0.000357	0.00704	CcSEcCtD
Fenoldopam—Diarrhoea—Methamphetamine—obesity	0.000351	0.00693	CcSEcCtD
Fenoldopam—Insomnia—Phenylpropanolamine—obesity	0.000349	0.00688	CcSEcCtD
Fenoldopam—Palpitations—Diethylpropion—obesity	0.000348	0.00685	CcSEcCtD
Fenoldopam—Dyspnoea—Phenylpropanolamine—obesity	0.000344	0.00678	CcSEcCtD
Fenoldopam—Dizziness—Methamphetamine—obesity	0.00034	0.0067	CcSEcCtD
Fenoldopam—Diarrhoea—Benzphetamine—obesity	0.000339	0.00668	CcSEcCtD
Fenoldopam—Chest pain—Diethylpropion—obesity	0.000335	0.0066	CcSEcCtD
Fenoldopam—Insomnia—Phentermine—obesity	0.000334	0.00658	CcSEcCtD
Fenoldopam—Anxiety—Diethylpropion—obesity	0.000334	0.00658	CcSEcCtD
Fenoldopam—Constipation—Phenylpropanolamine—obesity	0.00033	0.0065	CcSEcCtD
Fenoldopam—Dizziness—Benzphetamine—obesity	0.000328	0.00646	CcSEcCtD
Fenoldopam—Headache—Methamphetamine—obesity	0.000322	0.00634	CcSEcCtD
Fenoldopam—Nasal congestion—Bupropion—obesity	0.000318	0.00626	CcSEcCtD
Fenoldopam—Anxiety—Cimetidine—obesity	0.000318	0.00626	CcSEcCtD
Fenoldopam—Constipation—Phentermine—obesity	0.000316	0.00622	CcSEcCtD
Fenoldopam—Tachycardia—Diethylpropion—obesity	0.000313	0.00618	CcSEcCtD
Fenoldopam—Hypokalaemia—Orlistat—obesity	0.000312	0.00616	CcSEcCtD
Fenoldopam—Blood creatinine increased—Sibutramine—obesity	0.000311	0.00613	CcSEcCtD
Fenoldopam—Hyperhidrosis—Diethylpropion—obesity	0.00031	0.00612	CcSEcCtD
Fenoldopam—Headache—Benzphetamine—obesity	0.00031	0.00612	CcSEcCtD
Fenoldopam—Diarrhoea—Phendimetrazine—obesity	0.000309	0.00609	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Sibutramine—obesity	0.000303	0.00598	CcSEcCtD
Fenoldopam—Hypokalaemia—Sibutramine—obesity	0.000302	0.00596	CcSEcCtD
Fenoldopam—Dizziness—Phendimetrazine—obesity	0.000299	0.00589	CcSEcCtD
Fenoldopam—Tachycardia—Cimetidine—obesity	0.000298	0.00588	CcSEcCtD
Fenoldopam—Nausea—Benzphetamine—obesity	0.000294	0.0058	CcSEcCtD
Fenoldopam—Abdominal pain—Phentermine—obesity	0.000292	0.00575	CcSEcCtD
Fenoldopam—Insomnia—Diethylpropion—obesity	0.00029	0.00572	CcSEcCtD
Fenoldopam—Dyspnoea—Diethylpropion—obesity	0.000286	0.00564	CcSEcCtD
Fenoldopam—Headache—Phendimetrazine—obesity	0.000283	0.00558	CcSEcCtD
Fenoldopam—Angina pectoris—Sibutramine—obesity	0.00028	0.00551	CcSEcCtD
Fenoldopam—Oliguria—Topiramate—obesity	0.000276	0.00544	CcSEcCtD
Fenoldopam—Constipation—Diethylpropion—obesity	0.000275	0.00541	CcSEcCtD
Fenoldopam—Nausea—Phendimetrazine—obesity	0.000268	0.00529	CcSEcCtD
Fenoldopam—Creatinine increased—Topiramate—obesity	0.000267	0.00526	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Bupropion—obesity	0.000264	0.00521	CcSEcCtD
Fenoldopam—Constipation—Cimetidine—obesity	0.000261	0.00515	CcSEcCtD
Fenoldopam—Urinary tract infection—Orlistat—obesity	0.000257	0.00507	CcSEcCtD
Fenoldopam—Dizziness—Phenylpropanolamine—obesity	0.000255	0.00503	CcSEcCtD
Fenoldopam—Diarrhoea—Phentermine—obesity	0.000253	0.00498	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Sibutramine—obesity	0.000252	0.00497	CcSEcCtD
Fenoldopam—Myocardial infarction—Sibutramine—obesity	0.000251	0.00495	CcSEcCtD
Fenoldopam—Urinary tract infection—Sibutramine—obesity	0.000249	0.0049	CcSEcCtD
Fenoldopam—Sweating—Sibutramine—obesity	0.000245	0.00484	CcSEcCtD
Fenoldopam—Vomiting—Phenylpropanolamine—obesity	0.000245	0.00483	CcSEcCtD
Fenoldopam—Dizziness—Phentermine—obesity	0.000244	0.00481	CcSEcCtD
Fenoldopam—Body temperature increased—Cimetidine—obesity	0.000241	0.00476	CcSEcCtD
Fenoldopam—Haemoglobin—Orlistat—obesity	0.000239	0.0047	CcSEcCtD
Fenoldopam—Haemorrhage—Orlistat—obesity	0.000237	0.00468	CcSEcCtD
Fenoldopam—Vomiting—Phentermine—obesity	0.000235	0.00463	CcSEcCtD
Fenoldopam—Bradycardia—Sibutramine—obesity	0.000234	0.00461	CcSEcCtD
Fenoldopam—Headache—Phentermine—obesity	0.000231	0.00456	CcSEcCtD
Fenoldopam—Haemoglobin—Sibutramine—obesity	0.000231	0.00455	CcSEcCtD
Fenoldopam—Haemorrhage—Sibutramine—obesity	0.00023	0.00453	CcSEcCtD
Fenoldopam—Nausea—Phenylpropanolamine—obesity	0.000229	0.00452	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Bupropion—obesity	0.00022	0.00434	CcSEcCtD
Fenoldopam—Diarrhoea—Diethylpropion—obesity	0.00022	0.00433	CcSEcCtD
Fenoldopam—Nausea—Phentermine—obesity	0.000219	0.00432	CcSEcCtD
Fenoldopam—Myocardial infarction—Bupropion—obesity	0.000219	0.00431	CcSEcCtD
Fenoldopam—Urinary tract infection—Bupropion—obesity	0.000217	0.00428	CcSEcCtD
Fenoldopam—Sweating—Bupropion—obesity	0.000214	0.00422	CcSEcCtD
Fenoldopam—Dizziness—Diethylpropion—obesity	0.000212	0.00419	CcSEcCtD
Fenoldopam—Diarrhoea—Cimetidine—obesity	0.000209	0.00412	CcSEcCtD
Fenoldopam—Vomiting—Diethylpropion—obesity	0.000204	0.00402	CcSEcCtD
Fenoldopam—Nasal congestion—Topiramate—obesity	0.000202	0.00399	CcSEcCtD
Fenoldopam—Dizziness—Cimetidine—obesity	0.000202	0.00398	CcSEcCtD
Fenoldopam—Haemoglobin—Bupropion—obesity	0.000201	0.00397	CcSEcCtD
Fenoldopam—Headache—Diethylpropion—obesity	0.000201	0.00396	CcSEcCtD
Fenoldopam—Haemorrhage—Bupropion—obesity	0.0002	0.00395	CcSEcCtD
Fenoldopam—Back pain—Orlistat—obesity	0.0002	0.00394	CcSEcCtD
Fenoldopam—Muscle spasms—Orlistat—obesity	0.000199	0.00392	CcSEcCtD
Fenoldopam—Tension—Sibutramine—obesity	0.000196	0.00387	CcSEcCtD
Fenoldopam—Nervousness—Sibutramine—obesity	0.000194	0.00383	CcSEcCtD
Fenoldopam—Vomiting—Cimetidine—obesity	0.000194	0.00383	CcSEcCtD
Fenoldopam—Back pain—Sibutramine—obesity	0.000193	0.00381	CcSEcCtD
Fenoldopam—Muscle spasms—Sibutramine—obesity	0.000192	0.00379	CcSEcCtD
Fenoldopam—Headache—Cimetidine—obesity	0.000191	0.00377	CcSEcCtD
Fenoldopam—Nausea—Diethylpropion—obesity	0.000191	0.00376	CcSEcCtD
Fenoldopam—Flushing—Bupropion—obesity	0.000186	0.00366	CcSEcCtD
Fenoldopam—Palpitations—Orlistat—obesity	0.000183	0.0036	CcSEcCtD
Fenoldopam—Nausea—Cimetidine—obesity	0.000181	0.00358	CcSEcCtD
Fenoldopam—Palpitations—Sibutramine—obesity	0.000177	0.00348	CcSEcCtD
Fenoldopam—Chest pain—Orlistat—obesity	0.000176	0.00347	CcSEcCtD
Fenoldopam—Anxiety—Orlistat—obesity	0.000175	0.00346	CcSEcCtD
Fenoldopam—Blood creatinine increased—Topiramate—obesity	0.000173	0.00341	CcSEcCtD
Fenoldopam—Tension—Bupropion—obesity	0.000171	0.00337	CcSEcCtD
Fenoldopam—Chest pain—Sibutramine—obesity	0.00017	0.00336	CcSEcCtD
Fenoldopam—Anxiety—Sibutramine—obesity	0.00017	0.00334	CcSEcCtD
Fenoldopam—Nervousness—Bupropion—obesity	0.000169	0.00334	CcSEcCtD
Fenoldopam—Back pain—Bupropion—obesity	0.000169	0.00332	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Topiramate—obesity	0.000168	0.00332	CcSEcCtD
Fenoldopam—Hypokalaemia—Topiramate—obesity	0.000168	0.00331	CcSEcCtD
Fenoldopam—Muscle spasms—Bupropion—obesity	0.000168	0.0033	CcSEcCtD
Fenoldopam—Hyperhidrosis—Orlistat—obesity	0.000163	0.00321	CcSEcCtD
Fenoldopam—Tachycardia—Sibutramine—obesity	0.000159	0.00314	CcSEcCtD
Fenoldopam—Hyperhidrosis—Sibutramine—obesity	0.000158	0.00311	CcSEcCtD
Fenoldopam—Angina pectoris—Topiramate—obesity	0.000155	0.00306	CcSEcCtD
Fenoldopam—Palpitations—Bupropion—obesity	0.000154	0.00304	CcSEcCtD
Fenoldopam—Insomnia—Orlistat—obesity	0.000153	0.00301	CcSEcCtD
Fenoldopam—Hypotension—Sibutramine—obesity	0.000153	0.00301	CcSEcCtD
Fenoldopam—Chest pain—Bupropion—obesity	0.000148	0.00293	CcSEcCtD
Fenoldopam—Anxiety—Bupropion—obesity	0.000148	0.00292	CcSEcCtD
Fenoldopam—Insomnia—Sibutramine—obesity	0.000148	0.00291	CcSEcCtD
Fenoldopam—Dyspnoea—Sibutramine—obesity	0.000146	0.00287	CcSEcCtD
Fenoldopam—Constipation—Sibutramine—obesity	0.00014	0.00275	CcSEcCtD
Fenoldopam—Tachycardia—Bupropion—obesity	0.000139	0.00274	CcSEcCtD
Fenoldopam—Urinary tract infection—Topiramate—obesity	0.000138	0.00272	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Orlistat—obesity	0.000138	0.00272	CcSEcCtD
Fenoldopam—Hyperhidrosis—Bupropion—obesity	0.000138	0.00271	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Sibutramine—obesity	0.000133	0.00263	CcSEcCtD
Fenoldopam—Abdominal pain—Orlistat—obesity	0.000133	0.00263	CcSEcCtD
Fenoldopam—Body temperature increased—Orlistat—obesity	0.000133	0.00263	CcSEcCtD
Fenoldopam—Hypotension—Bupropion—obesity	0.000133	0.00262	CcSEcCtD
Fenoldopam—Bradycardia—Topiramate—obesity	0.00013	0.00256	CcSEcCtD
Fenoldopam—Body temperature increased—Sibutramine—obesity	0.000129	0.00254	CcSEcCtD
Fenoldopam—Abdominal pain—Sibutramine—obesity	0.000129	0.00254	CcSEcCtD
Fenoldopam—Insomnia—Bupropion—obesity	0.000129	0.00254	CcSEcCtD
Fenoldopam—Haemoglobin—Topiramate—obesity	0.000128	0.00253	CcSEcCtD
Fenoldopam—Haemorrhage—Topiramate—obesity	0.000128	0.00252	CcSEcCtD
Fenoldopam—Dyspnoea—Bupropion—obesity	0.000127	0.0025	CcSEcCtD
Fenoldopam—Constipation—Bupropion—obesity	0.000122	0.0024	CcSEcCtD
Fenoldopam—Flushing—Topiramate—obesity	0.000118	0.00233	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Bupropion—obesity	0.000116	0.00229	CcSEcCtD
Fenoldopam—Diarrhoea—Orlistat—obesity	0.000115	0.00227	CcSEcCtD
Fenoldopam—Abdominal pain—Bupropion—obesity	0.000112	0.00222	CcSEcCtD
Fenoldopam—Body temperature increased—Bupropion—obesity	0.000112	0.00222	CcSEcCtD
Fenoldopam—Diarrhoea—Sibutramine—obesity	0.000112	0.0022	CcSEcCtD
Fenoldopam—Dizziness—Orlistat—obesity	0.000112	0.0022	CcSEcCtD
Fenoldopam—Tension—Topiramate—obesity	0.000109	0.00215	CcSEcCtD
Fenoldopam—Dizziness—Sibutramine—obesity	0.000108	0.00213	CcSEcCtD
Fenoldopam—Nervousness—Topiramate—obesity	0.000108	0.00213	CcSEcCtD
Fenoldopam—Back pain—Topiramate—obesity	0.000107	0.00212	CcSEcCtD
Fenoldopam—Vomiting—Orlistat—obesity	0.000107	0.00211	CcSEcCtD
Fenoldopam—Muscle spasms—Topiramate—obesity	0.000107	0.00211	CcSEcCtD
Fenoldopam—Headache—Orlistat—obesity	0.000106	0.00208	CcSEcCtD
Fenoldopam—Vomiting—Sibutramine—obesity	0.000104	0.00205	CcSEcCtD
Fenoldopam—Headache—Sibutramine—obesity	0.000102	0.00202	CcSEcCtD
Fenoldopam—Nausea—Orlistat—obesity	0.0001	0.00197	CcSEcCtD
Fenoldopam—Palpitations—Topiramate—obesity	9.82e-05	0.00194	CcSEcCtD
Fenoldopam—Diarrhoea—Bupropion—obesity	9.74e-05	0.00192	CcSEcCtD
Fenoldopam—Nausea—Sibutramine—obesity	9.7e-05	0.00191	CcSEcCtD
Fenoldopam—Chest pain—Topiramate—obesity	9.46e-05	0.00186	CcSEcCtD
Fenoldopam—Anxiety—Topiramate—obesity	9.42e-05	0.00186	CcSEcCtD
Fenoldopam—Dizziness—Bupropion—obesity	9.41e-05	0.00185	CcSEcCtD
Fenoldopam—Vomiting—Bupropion—obesity	9.05e-05	0.00178	CcSEcCtD
Fenoldopam—Headache—Bupropion—obesity	8.91e-05	0.00176	CcSEcCtD
Fenoldopam—Tachycardia—Topiramate—obesity	8.85e-05	0.00174	CcSEcCtD
Fenoldopam—Hyperhidrosis—Topiramate—obesity	8.76e-05	0.00173	CcSEcCtD
Fenoldopam—Hypotension—Topiramate—obesity	8.47e-05	0.00167	CcSEcCtD
Fenoldopam—Nausea—Bupropion—obesity	8.45e-05	0.00167	CcSEcCtD
Fenoldopam—Insomnia—Topiramate—obesity	8.2e-05	0.00162	CcSEcCtD
Fenoldopam—Dyspnoea—Topiramate—obesity	8.08e-05	0.00159	CcSEcCtD
Fenoldopam—Constipation—Topiramate—obesity	7.75e-05	0.00153	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Topiramate—obesity	7.41e-05	0.00146	CcSEcCtD
Fenoldopam—Abdominal pain—Topiramate—obesity	7.17e-05	0.00141	CcSEcCtD
Fenoldopam—Body temperature increased—Topiramate—obesity	7.17e-05	0.00141	CcSEcCtD
Fenoldopam—Diarrhoea—Topiramate—obesity	6.2e-05	0.00122	CcSEcCtD
Fenoldopam—Dizziness—Topiramate—obesity	5.99e-05	0.00118	CcSEcCtD
Fenoldopam—Vomiting—Topiramate—obesity	5.76e-05	0.00114	CcSEcCtD
Fenoldopam—Headache—Topiramate—obesity	5.68e-05	0.00112	CcSEcCtD
Fenoldopam—Nausea—Topiramate—obesity	5.38e-05	0.00106	CcSEcCtD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CG—obesity	1.45e-06	2.2e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3R1—obesity	1.45e-06	2.2e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOS3—obesity	1.45e-06	2.2e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL2—obesity	1.45e-06	2.19e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CAV1—obesity	1.45e-06	2.19e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MYC—obesity	1.45e-06	2.19e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—RHOA—obesity	1.45e-06	2.19e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APOA1—obesity	1.45e-06	2.19e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TGFB1—obesity	1.44e-06	2.19e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3R1—obesity	1.44e-06	2.19e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—NOS3—obesity	1.44e-06	2.19e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IRS2—obesity	1.44e-06	2.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRKCD—obesity	1.44e-06	2.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AGT—obesity	1.44e-06	2.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IRS1—obesity	1.44e-06	2.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3R1—obesity	1.43e-06	2.17e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOS3—obesity	1.43e-06	2.17e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CG—obesity	1.43e-06	2.17e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IGF1—obesity	1.43e-06	2.16e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT2—obesity	1.42e-06	2.16e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IRS1—obesity	1.42e-06	2.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CG—obesity	1.41e-06	2.14e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOE—obesity	1.41e-06	2.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—LEP—obesity	1.41e-06	2.13e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HTR2A—obesity	1.41e-06	2.13e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—C3—obesity	1.41e-06	2.13e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ESR1—obesity	1.4e-06	2.11e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CAV1—obesity	1.4e-06	2.11e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOA1—obesity	1.39e-06	2.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—POMC—obesity	1.38e-06	2.1e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—PIK3CA—obesity	1.38e-06	2.09e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—F2—obesity	1.38e-06	2.09e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PRKCB—obesity	1.38e-06	2.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—INS—obesity	1.38e-06	2.08e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CD—obesity	1.37e-06	2.07e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—PIK3CA—obesity	1.36e-06	2.06e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PPARG—obesity	1.36e-06	2.06e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—BAD—obesity	1.36e-06	2.06e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—POMC—obesity	1.36e-06	2.06e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—PIK3CA—obesity	1.36e-06	2.05e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—INS—obesity	1.36e-06	2.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL2—obesity	1.35e-06	2.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SERPINE1—obesity	1.35e-06	2.05e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ESR1—obesity	1.35e-06	2.04e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—POMC—obesity	1.35e-06	2.04e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CB—obesity	1.34e-06	2.03e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MTOR—obesity	1.34e-06	2.03e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IRS2—obesity	1.34e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—INS—obesity	1.34e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AGT—obesity	1.34e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL2—obesity	1.33e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CB—obesity	1.33e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IGF1—obesity	1.33e-06	2.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT2—obesity	1.33e-06	2.01e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—AKT1—obesity	1.33e-06	2.01e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PRKCB—obesity	1.33e-06	2.01e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—F2—obesity	1.33e-06	2.01e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CB—obesity	1.32e-06	2e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MTOR—obesity	1.32e-06	2e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—obesity	1.32e-06	2e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CG—obesity	1.32e-06	2e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TYK2—obesity	1.32e-06	1.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—BAD—obesity	1.31e-06	1.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IGF1—obesity	1.31e-06	1.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT2—obesity	1.31e-06	1.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—LEP—obesity	1.31e-06	1.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOE—obesity	1.31e-06	1.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RHOA—obesity	1.31e-06	1.98e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IRS1—obesity	1.3e-06	1.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CAV1—obesity	1.3e-06	1.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOA1—obesity	1.29e-06	1.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOS3—obesity	1.29e-06	1.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3R1—obesity	1.29e-06	1.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CD—obesity	1.28e-06	1.93e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CG—obesity	1.27e-06	1.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	1.27e-06	1.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SERPINE1—obesity	1.26e-06	1.91e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CD—obesity	1.26e-06	1.9e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IRS1—obesity	1.26e-06	1.9e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—POMC—obesity	1.26e-06	1.9e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ESR1—obesity	1.25e-06	1.89e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—INS—obesity	1.25e-06	1.89e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	1.25e-06	1.89e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SERPINE1—obesity	1.24e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKT1—obesity	1.24e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CD—obesity	1.24e-06	1.88e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRKCB—obesity	1.23e-06	1.87e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—F2—obesity	1.23e-06	1.87e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PIK3CA—obesity	1.23e-06	1.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TYK2—obesity	1.23e-06	1.86e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL2—obesity	1.23e-06	1.86e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PIK3CA—obesity	1.23e-06	1.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKT1—obesity	1.23e-06	1.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—obesity	1.23e-06	1.86e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—obesity	1.22e-06	1.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RHOA—obesity	1.22e-06	1.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BAD—obesity	1.22e-06	1.85e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TYK2—obesity	1.21e-06	1.83e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—POMC—obesity	1.21e-06	1.83e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IGF1—obesity	1.21e-06	1.83e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—obesity	1.21e-06	1.83e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT2—obesity	1.21e-06	1.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3R1—obesity	1.21e-06	1.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOS3—obesity	1.21e-06	1.83e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—INS—obesity	1.2e-06	1.82e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RHOA—obesity	1.2e-06	1.82e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MTOR—obesity	1.19e-06	1.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CB—obesity	1.19e-06	1.81e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3R1—obesity	1.19e-06	1.8e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOS3—obesity	1.19e-06	1.8e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL2—obesity	1.18e-06	1.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CG—obesity	1.18e-06	1.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3R1—obesity	1.17e-06	1.77e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—NOS3—obesity	1.17e-06	1.77e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IRS1—obesity	1.17e-06	1.77e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IGF1—obesity	1.16e-06	1.76e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—obesity	1.16e-06	1.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT2—obesity	1.16e-06	1.76e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CD—obesity	1.16e-06	1.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PIK3CA—obesity	1.15e-06	1.74e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—PIK3CA—obesity	1.15e-06	1.74e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—obesity	1.15e-06	1.74e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SERPINE1—obesity	1.15e-06	1.74e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK8—obesity	1.13e-06	1.71e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PIK3CA—obesity	1.13e-06	1.71e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—obesity	1.13e-06	1.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—POMC—obesity	1.12e-06	1.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—INS—obesity	1.12e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CD—obesity	1.12e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK8—obesity	1.12e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TYK2—obesity	1.12e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MTOR—obesity	1.11e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CB—obesity	1.11e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—obesity	1.11e-06	1.69e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—obesity	1.11e-06	1.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	1.11e-06	1.68e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RHOA—obesity	1.11e-06	1.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—obesity	1.11e-06	1.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL2—obesity	1.1e-06	1.67e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MTOR—obesity	1.1e-06	1.66e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CB—obesity	1.1e-06	1.66e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOS3—obesity	1.1e-06	1.66e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3R1—obesity	1.1e-06	1.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—obesity	1.09e-06	1.65e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—obesity	1.09e-06	1.65e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CB—obesity	1.08e-06	1.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1—obesity	1.08e-06	1.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT2—obesity	1.08e-06	1.64e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TYK2—obesity	1.08e-06	1.63e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—obesity	1.07e-06	1.62e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RHOA—obesity	1.07e-06	1.61e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3R1—obesity	1.06e-06	1.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOS3—obesity	1.06e-06	1.6e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CA—obesity	1.04e-06	1.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.04e-06	1.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—obesity	1.04e-06	1.57e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—obesity	1.04e-06	1.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—obesity	1.03e-06	1.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.03e-06	1.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.03e-06	1.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—obesity	1.02e-06	1.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—obesity	1.02e-06	1.54e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—obesity	1.02e-06	1.54e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MTOR—obesity	1.01e-06	1.53e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CB—obesity	1.01e-06	1.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK8—obesity	1.01e-06	1.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—obesity	1.01e-06	1.52e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CA—obesity	1.01e-06	1.52e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—obesity	1e-06	1.52e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—obesity	1e-06	1.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TYK2—obesity	9.99e-07	1.51e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RHOA—obesity	9.91e-07	1.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3R1—obesity	9.81e-07	1.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOS3—obesity	9.81e-07	1.48e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MTOR—obesity	9.74e-07	1.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CB—obesity	9.74e-07	1.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—obesity	9.69e-07	1.47e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—obesity	9.62e-07	1.46e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—obesity	9.6e-07	1.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—obesity	9.54e-07	1.44e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—obesity	9.49e-07	1.44e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—obesity	9.47e-07	1.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK8—obesity	9.42e-07	1.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—obesity	9.4e-07	1.42e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—obesity	9.39e-07	1.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CA—obesity	9.34e-07	1.41e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK8—obesity	9.27e-07	1.4e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—obesity	9.25e-07	1.4e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—obesity	9.24e-07	1.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—obesity	9.22e-07	1.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MTOR—obesity	9.05e-07	1.37e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CB—obesity	9.05e-07	1.37e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—obesity	9.05e-07	1.37e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—obesity	8.9e-07	1.35e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—obesity	8.79e-07	1.33e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—obesity	8.61e-07	1.3e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—obesity	8.57e-07	1.3e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK8—obesity	8.55e-07	1.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—obesity	8.55e-07	1.29e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—obesity	8.53e-07	1.29e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—obesity	8.48e-07	1.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—obesity	8.47e-07	1.28e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—obesity	8.4e-07	1.27e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—obesity	8.27e-07	1.25e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK8—obesity	8.24e-07	1.25e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—obesity	8.21e-07	1.24e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CA—obesity	8.17e-07	1.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CA—obesity	8.13e-07	1.23e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CA—obesity	8.06e-07	1.22e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—obesity	8e-07	1.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—obesity	7.99e-07	1.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—obesity	7.88e-07	1.19e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—obesity	7.87e-07	1.19e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—obesity	7.86e-07	1.19e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—obesity	7.82e-07	1.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK8—obesity	7.65e-07	1.16e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—obesity	7.63e-07	1.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—obesity	7.53e-07	1.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CA—obesity	7.27e-07	1.1e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—obesity	7.26e-07	1.1e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—obesity	7.25e-07	1.1e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—obesity	7.23e-07	1.09e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—obesity	7.13e-07	1.08e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—obesity	7e-07	1.06e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—obesity	7e-07	1.06e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—obesity	6.98e-07	1.06e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CA—obesity	6.8e-07	1.03e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CA—obesity	6.69e-07	1.01e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—obesity	6.67e-07	1.01e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—obesity	6.64e-07	1e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CA—obesity	6.6e-07	9.99e-06	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—obesity	6.58e-07	9.96e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—obesity	6.5e-07	9.84e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—obesity	6.49e-07	9.81e-06	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—obesity	6.44e-07	9.75e-06	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CA—obesity	6.17e-07	9.33e-06	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—obesity	6.02e-07	9.1e-06	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—obesity	5.94e-07	8.99e-06	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CA—obesity	5.94e-07	8.99e-06	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—obesity	5.92e-07	8.96e-06	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—obesity	5.55e-07	8.4e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CA—obesity	5.52e-07	8.35e-06	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—obesity	5.46e-07	8.27e-06	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—obesity	5.46e-07	8.26e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—obesity	5.39e-07	8.16e-06	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—obesity	5.26e-07	7.96e-06	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—obesity	5.04e-07	7.62e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—obesity	4.89e-07	7.39e-06	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—obesity	4.85e-07	7.34e-06	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—obesity	4.51e-07	6.82e-06	CbGpPWpGaD
